F-star Therapeutics, Inc. - Common Stock (NQ:FSTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 8, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about F-star Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Week In Review: Sino Biopharma Acquires F-Star For $161 Million After US Approval ↗

March 11, 2023

Sino Biopharma was approved to close its $161 million all-cash acquisition of F-Star. The purchase didn't look like would happen after it was held up for nine months by the US government’s Committee on...

Via Talk Markets

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.

March 08, 2023

From invoX Pharma

Via Business Wire

Why F-Star Therapeutics Shares Are Moving Higher ↗

March 07, 2023

F-Star Therapeutics Inc (NASDAQ: FSTX) shares are trading higher Tuesday after the company announced clearance for the proposed acquisition by invoX Ph

Via Benzinga

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

March 07, 2023

Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender Offer

From F-star Therapeutics, Inc.

Via GlobeNewswire

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 07, 2023

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 01, 2023

Via Benzinga

Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗

January 27, 2023

Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I...

Via Benzinga

invoX Pharma and F-star Therapeutics issue Joint Statement

January 26, 2023

From F-star Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 26, 2023

Via Benzinga

Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 26, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 30, 2022

Via Benzinga

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...

Via Benzinga

US Stocks Open Lower; Dow Drops 250 Points ↗

December 30, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 30, 2022

Via Benzinga

Why F-Star Therapeutics Stock Is Getting Obliterated During Thursday's Session ↗

December 29, 2022

F-Star Therapeutics Inc (NASDAQ: FSTX) shares are trading lower by 39.94% to $4.12 Thursday afternoon after the Committee on Foreign Investment issued an interim order preventing the closing of the...

Via Benzinga

Dow Rises Over 1%; Cal-Maine Foods Shares Plummet ↗

December 29, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 250 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 29, 2022

Via Benzinga

Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗

December 29, 2022

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.

Via Benzinga

Nasdaq Jumps Over 250 Points; Crude Oil Down 1% ↗

December 29, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones climbing around 400 points on Thursday.

Via Benzinga

Dow Surges 250 Points; Jobless Claims Rise To 225,000 ↗

December 29, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.

Via Benzinga

Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session ↗

December 21, 2022

Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 21, 2022

Via Benzinga

Dow Surges 300 Points; US Current Account Deficit Narrows In Third Quarter ↗

December 21, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 21, 2022

Via Benzinga

F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress

December 06, 2022

FS222 demonstrated early antitumor activity with one complete response and six disease stabilizations in patients with advanced solid tumors

From F-star Therapeutics, Inc.

Via GlobeNewswire

F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research

November 07, 2022

From F-star Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.